Nazione: Regno Unito
Lingua: inglese
Fonte: MHRA (Medicines & Healthcare Products Regulatory Agency)
Epoprostenol sodium
pH10.5) for solution for infusion vials (Advanz Pharma
B01AC09
Epoprostenol sodium
1.5mg
Powder and solvent for solution for infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 02080100; GTIN: 5099602001671